Corteva Inc (CTVA)

Currency in USD
12.88
0.00(0.00%)
Closed·
12.80-0.08(-0.62%)
·
High dividend Yield
CTVA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.6913.17
52 wk Range
11.4890.97
Key Statistics
Prev. Close
12.88
Open
12.99
Day's Range
12.69-13.17
52 wk Range
11.48-90.97
Volume
11.03M
Average Volume (3m)
13.01M
1-Year Change
-78.8852%
Book Value / Share
NA
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CTVA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
22.05
Upside
+71.23%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Corteva Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

9 Buy
3 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 22.05
(+71.23% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Hold15.00+16.46%90.00MaintainOct 12, 2026
Goldman Sachs
Buy20.00+55.28%96.00MaintainOct 08, 2026
RBC Capital
Buy17.00+31.99%103.00MaintainOct 07, 2026
KeyBanc
Buy17.00+31.99%-UpgradeOct 07, 2026
JPMorgan
Buy19.00+47.52%83.00UpgradeOct 06, 2026

Corteva Inc SWOT Analysis


Agribusiness Giant
Corteva, a leading player in global agriculture, boasts strong financials with a "GOOD" health score, focusing on seeds and crop protection chemicals
Financial Resilience
Explore Corteva's impressive metrics: 45.7% gross profit margin, 12.5% YoY dividend growth, and an ambitious 2027 EBITDA target of $4.1-$4.4 billion
Market Challenges
Delve into Corteva's navigation of global supply chain issues, pricing pressures, and the debate surrounding potential business restructuring
Growth Prospects
Learn about Corteva's innovative product pipeline, including Enlist seed technology and biological products, driving its competitive edge in key markets
Read full SWOT analysis

Corteva Inc Earnings Call Summary for Q2/2026

  • Corteva Q2 EPS beat at $2.30 vs. $2.22 est., but revenue missed at $6.38B vs. $6.57B; shares fell 10% to $80.39 amid pricing pressures in Brazil.
  • Raised FY2026 guidance: operating EBITDA to $4.1B-$4.3B (up 9%) and operating EPS to $3.60-$3.80 (up 11%); reaffirmed 2027 EBITDA target of $4.4B.
  • H1 net sales rose 4% to $11.3B; operating EBITDA up 10% to $3.7B with 200bps margin expansion to 32.8% driven by productivity and lower input costs.
  • Company remains on track to separate into two public entities Oct. 1; dis-synergies reduced from $100M to $25M; investor days scheduled Sept. 15.
  • Q3 expected to post $100M EBITDA loss with Q4 carrying most H2 earnings; seven new crop protection actives planned over next decade led by Haviza fungicide.
Last Updated: 07/31/2026, 10:16 PM
Read Full Transcript

Earnings

Latest Release
Jul 30, 2026
EPS / Forecast
2.30 / 2.22
Revenue / Forecast
6.38B / 6.57B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.19
Dividend Yield
5.59%
Industry Median 2.37%
Annualized payout
0.72
Paid quarterly
5-Years Growth
+6.32%
Growth Streak

CTVA Income Statement

Compare CTVA to Peers and Sector

Metrics to compare
CTVA
Peers
Sector
Relationship
P/E Ratio
68.2x21.8x4.1x
PEG Ratio
-−0.390.00
Price/Book
0.9x1.3x1.6x
Price / LTM Sales
1.7x1.2x1.2x
Upside (Analyst Target)
71.5%17.6%48.7%
Fair Value Upside
Unlock3.8%5.2%Unlock

Corteva, Inc. operates as a pure-play agriculture company in the United States, Canada, the Middle East, Africa, Europe, Latin America, and Asia. The company provides products that protect against weeds, insects, diseases, nematodes, and other pests, as well as supports crop health via nitrogen management and seed-applied technologies. Its crop protection solutions and digital solutions provide farmers tools to improve productivity and help keep fields free of weeds, insects, and diseases. The company offers herbicides, soybeans, cereals, fruits and vegetables, insecticides, nitrogen stabilizers, pasture, and a range management herbicides and biologicals and other nature-based products. The company is headquartered in Indianapolis, Indiana.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
15.88K0.00%212.85K
Other Institutional Investors
0.000.00%0.00
Public Companies & Retail Investors
667.38M100.00%8.94B
Total
667.39M100.00%8.94B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
New York Life Investment Management LLC0.00%15,884213
NYLIM ETF Trust - NYLIM U.S. Large Cap R&D Leaders ETF0.00%15,751211

People Also Watch

152.01
VST
-1.40%
169.70
CRDO
-4.93%
824.13
LITE
-5.22%
271.37
CEG
-1.32%
227.83
MRVL
-5.56%

FAQ

What Is the Corteva (CTVA) Stock Price Today?

The Corteva stock price today is 12.88 USD.

What Stock Exchange Does Corteva Trade On?

Corteva is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Corteva?

The stock symbol for Corteva is "CTVA."

Does Corteva Pay Dividends? What’s The Current Dividend Yield?

The Corteva dividend yield is 5.6%%.

What Is the Corteva Market Cap?

As of today, Corteva market cap is 8.57B USD.

What Is Corteva's Earnings Per Share (TTM)?

The Corteva EPS (TTM) is 0.19.

When Is the Next Corteva Earnings Date?

Corteva will release its next earnings report on Nov 11, 2026.

From a Technical Analysis Perspective, Is CTVA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Corteva Stock Split?

Corteva has split 0 times.

What is the current trading status of Corteva (CTVA)?

As of Oct 16, 2026, Corteva (CTVA) is trading at a price of 12.88 USD, with a previous close of 12.88 USD. The stock has fluctuated within a day range of 12.69 USD to 13.17 USD, while its 52-week range spans from 11.48 USD to 90.97 USD.

What Is Corteva (CTVA) Price Target According to Analysts?

The average 12-month price target for Corteva is 22.05 USD, with a high estimate of 75 USD and a low estimate of 13.65291 USD. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +71.23% Upside potential.

What Is the CTVA Premarket Price?

CTVA's last pre-market stock price is 12.92 USD. The pre-market share volume is 13,950.00, and the stock has decreased by 0.04, or 0.31%.

What Is the CTVA After Hours Price?

CTVA's last after hours stock price is 12.80 USD, the stock has decreased by -0.08, or -0.62%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.